Skip to main content
Erschienen in: The Patient - Patient-Centered Outcomes Research 3/2016

01.06.2016 | Original Research Article

Feasibility of Using Qualitative Interviews to Explore Patients’ Treatment Goals: Experience from Dermatology

verfasst von: Christine Blome, Kathrin von Usslar, Matthias Augustin

Erschienen in: The Patient - Patient-Centered Outcomes Research | Ausgabe 3/2016

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Qualitative interviews are used to assess understandability and content validity of patient-reported outcomes. However, the common approach of asking patients to paraphrase items may not be sufficient to completely reveal item content as understood by patients.

Objective

We used qualitative interviews to elicit more detailed information about patients’ understanding of treatment goal items for the Patient Benefit Index 2.0 (PBI 2.0). This questionnaire measures patient-relevant benefit from treatments for skin diseases by assessing goal importance prior to and goal attainment after treatment.

Methods

We interviewed 16 patients with psoriasis, atopic dermatitis, leg ulcers, and vitiligo. Patients were asked to elaborate in detail on their understanding of 15 treatment goal items. Subsequently, they were asked to suggest changes in item wording and to name missing treatment goals. Interview transcripts were analyzed according to an adapted approach of content analysis.

Results

The task was easy for the patients to understand, and they shared detailed information on what each goal meant to them. Results of the content analysis induced a range of revisions of the PBI 2.0 items, including changes in wording (four items) and item order (two items). Four items were deleted because they were found to be redundant or irrelevant, and one item was added to the list of treatment goals.

Conclusions

Asking patients to elaborate on their item understanding in qualitative interviews provided detailed insight into item content and understandability. This method has helped considerably to improve feasibility and content validity of the PBI 2.0.
Literatur
1.
Zurück zum Zitat Brédart A, Marrel A, Abetz-Webb L, et al. Interviewing to develop Patient-Reported Outcome (PRO) measures for clinical research: eliciting patients’ experience. Health Qual Life Outcomes. 2014;12:15.CrossRefPubMedPubMedCentral Brédart A, Marrel A, Abetz-Webb L, et al. Interviewing to develop Patient-Reported Outcome (PRO) measures for clinical research: eliciting patients’ experience. Health Qual Life Outcomes. 2014;12:15.CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Leidy NK, Vernon M. Perspectives on patient-reported outcomes. Pharmaco Economics. 2008;26:363–70.CrossRef Leidy NK, Vernon M. Perspectives on patient-reported outcomes. Pharmaco Economics. 2008;26:363–70.CrossRef
3.
Zurück zum Zitat Patrick DL, Burke LB, Gwaltney CJ, et al. Content validity—establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: part 1—eliciting concepts for a new PRO instrument. Value Health. 2011;14:967–77.CrossRefPubMed Patrick DL, Burke LB, Gwaltney CJ, et al. Content validity—establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: part 1—eliciting concepts for a new PRO instrument. Value Health. 2011;14:967–77.CrossRefPubMed
4.
Zurück zum Zitat Fayers PM, Machin D. Quality of life: the assessment, analysis and interpretation of patient-reported outcomes. 2nd ed. Chichester: Wiley; 2007.CrossRef Fayers PM, Machin D. Quality of life: the assessment, analysis and interpretation of patient-reported outcomes. 2nd ed. Chichester: Wiley; 2007.CrossRef
5.
Zurück zum Zitat Patrick DL, Burke LB, Gwaltney CJ, Leidy NK, Martin ML, Molsen E, Ring L. Content validity—establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO Good Research Practices Task Force report: part 2—assessing respondent understanding. Value Health. 2011;14(8):978–88.CrossRefPubMed Patrick DL, Burke LB, Gwaltney CJ, Leidy NK, Martin ML, Molsen E, Ring L. Content validity—establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO Good Research Practices Task Force report: part 2—assessing respondent understanding. Value Health. 2011;14(8):978–88.CrossRefPubMed
6.
Zurück zum Zitat Turner RR, Quittner AL, Parasuraman BM, Kallich JD, Cleeland CS, Mayo/FDA Patient-Reported Outcomes Consensus Meeting Group. Patient-reported outcomes: instrument development and selection issues. Value Health. 2007;10(Suppl 2):S86–93.CrossRefPubMed Turner RR, Quittner AL, Parasuraman BM, Kallich JD, Cleeland CS, Mayo/FDA Patient-Reported Outcomes Consensus Meeting Group. Patient-reported outcomes: instrument development and selection issues. Value Health. 2007;10(Suppl 2):S86–93.CrossRefPubMed
7.
Zurück zum Zitat Brod M, Tesler L, Christensen T. Qualitative research and content validity: developing best practices based on science and experience. Qual Life Res. 2009;18:1263–78.CrossRefPubMed Brod M, Tesler L, Christensen T. Qualitative research and content validity: developing best practices based on science and experience. Qual Life Res. 2009;18:1263–78.CrossRefPubMed
8.
Zurück zum Zitat Collins D. Pretesting survey instruments: an overview of cognitive methods. Qual Life Res. 2003;12(3):229–38.CrossRefPubMed Collins D. Pretesting survey instruments: an overview of cognitive methods. Qual Life Res. 2003;12(3):229–38.CrossRefPubMed
9.
Zurück zum Zitat Kiresuk T, Sherman R. Goal attainment scaling: a general method for evaluating comprehensive community mental health programs. Community Ment Health J. 1968;4:443–53.CrossRefPubMed Kiresuk T, Sherman R. Goal attainment scaling: a general method for evaluating comprehensive community mental health programs. Community Ment Health J. 1968;4:443–53.CrossRefPubMed
10.
Zurück zum Zitat Gerdes N. Rehabilitationseffekte bei „zielorientierter Ergebnismessung“. Ergebnisse der IRES-ZOE-Studie 1996/97. Deutsche Rentenversicherung. 1998;3/4:217–38. Gerdes N. Rehabilitationseffekte bei „zielorientierter Ergebnismessung“. Ergebnisse der IRES-ZOE-Studie 1996/97. Deutsche Rentenversicherung. 1998;3/4:217–38.
11.
Zurück zum Zitat Feuerhahn J, Blome C, Radtke MA, et al. Validation of the patient benefit index for the assessment of patient-relevant benefit in the treatment of psoriasis. Arch Dermatol Res. 2012;304:433–41.CrossRefPubMed Feuerhahn J, Blome C, Radtke MA, et al. Validation of the patient benefit index for the assessment of patient-relevant benefit in the treatment of psoriasis. Arch Dermatol Res. 2012;304:433–41.CrossRefPubMed
12.
Zurück zum Zitat Augustin M, Blome C, Zschocke I, et al. Benefit evaluation in the therapy of chronic wounds from the patients’ perspective—development and validation of a new method. Wound Repair Regen. 2012;20:8–14.CrossRefPubMed Augustin M, Blome C, Zschocke I, et al. Benefit evaluation in the therapy of chronic wounds from the patients’ perspective—development and validation of a new method. Wound Repair Regen. 2012;20:8–14.CrossRefPubMed
13.
Zurück zum Zitat Augustin M, Radtke MA, Zschocke I, et al. The patient benefit index: a novel approach in patient-defined outcomes measurement for skin diseases. Arch Dermatol Res. 2009;301:561–71.CrossRefPubMed Augustin M, Radtke MA, Zschocke I, et al. The patient benefit index: a novel approach in patient-defined outcomes measurement for skin diseases. Arch Dermatol Res. 2009;301:561–71.CrossRefPubMed
14.
Zurück zum Zitat Augustin M, Reich C, Schaefer I, et al. Development and validation of a new instrument for the assessment of patient-defined benefit in the treatment of acne. J Dtsch Dermatol Ges. 2008;6:113–20.CrossRefPubMed Augustin M, Reich C, Schaefer I, et al. Development and validation of a new instrument for the assessment of patient-defined benefit in the treatment of acne. J Dtsch Dermatol Ges. 2008;6:113–20.CrossRefPubMed
15.
Zurück zum Zitat Blome C, Maares J, Diepgen T, et al. Measurement of patient-relevant benefits in the treatment of chronic hand eczema—a novel approach. Contact Derm. 2009;61:39–45.CrossRefPubMed Blome C, Maares J, Diepgen T, et al. Measurement of patient-relevant benefits in the treatment of chronic hand eczema—a novel approach. Contact Derm. 2009;61:39–45.CrossRefPubMed
16.
Zurück zum Zitat Blome C, Augustin M, Siepmann D, et al. Measuring patient-relevant benefits in pruritus treatment: development and validation of a specific outcomes tool. Br J Dermatol. 2009;161:1143–8.CrossRefPubMed Blome C, Augustin M, Siepmann D, et al. Measuring patient-relevant benefits in pruritus treatment: development and validation of a specific outcomes tool. Br J Dermatol. 2009;161:1143–8.CrossRefPubMed
17.
Zurück zum Zitat Augustin M, Schäfer I, Rabini S, et al. Assessing the value of supportive skin care: development and validation of an instrument for evaluating patient-relevant benefit. Dermatology. 2009;218:255–9.CrossRefPubMed Augustin M, Schäfer I, Rabini S, et al. Assessing the value of supportive skin care: development and validation of an instrument for evaluating patient-relevant benefit. Dermatology. 2009;218:255–9.CrossRefPubMed
18.
Zurück zum Zitat Augustin M, Gajur AI, Reich C, et al. Benefit evaluation in vitiligo treatment: development and validation of a patient-defined outcome questionnaire. Dermatology. 2008;217:101–6.CrossRefPubMed Augustin M, Gajur AI, Reich C, et al. Benefit evaluation in vitiligo treatment: development and validation of a patient-defined outcome questionnaire. Dermatology. 2008;217:101–6.CrossRefPubMed
19.
Zurück zum Zitat Mrowietz U, Reich K. Psoriasis—new insights into pathogenesis and treatment. Dtsch Arzteblatt Int. 2009;106(1–2):11–8 (quiz 19). Mrowietz U, Reich K. Psoriasis—new insights into pathogenesis and treatment. Dtsch Arzteblatt Int. 2009;106(1–2):11–8 (quiz 19).
20.
Zurück zum Zitat Schäfer I, Rustenbach SJ, Radtke M, Augustin J, Glaeske G, Augustin M. Epidemiologie der psoriasis in Deutschland—Auswertung von Sekundärdaten einer gesetzlichen Krankenversicherung [Epidemiology of psoriasis in Germany—analysis of secondary health insurance data]. Das Gesundheitswesen. 2011;73(05):308–13.CrossRefPubMed Schäfer I, Rustenbach SJ, Radtke M, Augustin J, Glaeske G, Augustin M. Epidemiologie der psoriasis in Deutschland—Auswertung von Sekundärdaten einer gesetzlichen Krankenversicherung [Epidemiology of psoriasis in Germany—analysis of secondary health insurance data]. Das Gesundheitswesen. 2011;73(05):308–13.CrossRefPubMed
22.
Zurück zum Zitat Rüttermann M, Maier-Hasselmann A, Nink-Grebe B, Burckhardt M. Local treatment of chronic wounds: in patients with peripheral vascular disease, chronic venous insufficiency, and diabetes. Dtsch Ärzteblatt Int. 2013;110(3):25–31. Rüttermann M, Maier-Hasselmann A, Nink-Grebe B, Burckhardt M. Local treatment of chronic wounds: in patients with peripheral vascular disease, chronic venous insufficiency, and diabetes. Dtsch Ärzteblatt Int. 2013;110(3):25–31.
23.
Zurück zum Zitat Margolis DJ, Bilker W, Santanna J, Baumgarten M. Venous leg ulcer: incidence and prevalence in the elderly. J Am Acad Dermatol. 2002;46(3):381–6.CrossRefPubMed Margolis DJ, Bilker W, Santanna J, Baumgarten M. Venous leg ulcer: incidence and prevalence in the elderly. J Am Acad Dermatol. 2002;46(3):381–6.CrossRefPubMed
24.
Zurück zum Zitat Nutten S. Atopic dermatitis: global epidemiology and risk factors. Ann Nutr Metab. 2015;66(Suppl 1):8–16.CrossRefPubMed Nutten S. Atopic dermatitis: global epidemiology and risk factors. Ann Nutr Metab. 2015;66(Suppl 1):8–16.CrossRefPubMed
25.
Zurück zum Zitat Garmhausen D, Hagemann T, Bieber T, Dimitriou I, Fimmers R, Diepgen T, Novak N. Characterization of different courses of atopic dermatitis in adolescent and adult patients. Allergy. 2013;68(4):498–506.CrossRefPubMed Garmhausen D, Hagemann T, Bieber T, Dimitriou I, Fimmers R, Diepgen T, Novak N. Characterization of different courses of atopic dermatitis in adolescent and adult patients. Allergy. 2013;68(4):498–506.CrossRefPubMed
26.
Zurück zum Zitat Radtke MA, Schäfer I, Gajur A, Langenbruch A, Augustin M. Willingness-to-pay and quality of life in patients with vitiligo. Br J Dermatol. 2009;161(1):134–9.CrossRefPubMed Radtke MA, Schäfer I, Gajur A, Langenbruch A, Augustin M. Willingness-to-pay and quality of life in patients with vitiligo. Br J Dermatol. 2009;161(1):134–9.CrossRefPubMed
27.
Zurück zum Zitat Alikhan A, Felsten LM, Daly M, Petronic-Rosic V. Vitiligo: a comprehensive overview Part I. Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histopathology, etiology, and work-up. J Am Acad Dermatol. 2011;65(3):473–91.CrossRefPubMed Alikhan A, Felsten LM, Daly M, Petronic-Rosic V. Vitiligo: a comprehensive overview Part I. Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histopathology, etiology, and work-up. J Am Acad Dermatol. 2011;65(3):473–91.CrossRefPubMed
28.
Zurück zum Zitat Augustin M, Herberger K, Hintzen S, Heigel H, Franzke N, Schäfer I. Prevalence of skin lesions and need for treatment in a cohort of 90,880 workers. Br J Dermatol. 2011;165(4):865–73.CrossRefPubMed Augustin M, Herberger K, Hintzen S, Heigel H, Franzke N, Schäfer I. Prevalence of skin lesions and need for treatment in a cohort of 90,880 workers. Br J Dermatol. 2011;165(4):865–73.CrossRefPubMed
29.
Zurück zum Zitat Smith JA. Qualitative psychology: a practical guide to research methods. London: SAGE Publications Ltd; 2008. Smith JA. Qualitative psychology: a practical guide to research methods. London: SAGE Publications Ltd; 2008.
30.
Zurück zum Zitat Perneger TV, Courvoisier DS, Hudelson PM, Gayet-Ageron A. Sample size for pre-tests of questionnaires. Qual Life Res. 2015;24:147–51.CrossRefPubMed Perneger TV, Courvoisier DS, Hudelson PM, Gayet-Ageron A. Sample size for pre-tests of questionnaires. Qual Life Res. 2015;24:147–51.CrossRefPubMed
31.
Zurück zum Zitat Mayring P. Qualitative Content Analysis. In: Flick U, Kardorff E, Steinke I, editors. A companion to qualitative research. London: Sage Publications; 2004. p. 266–9. Mayring P. Qualitative Content Analysis. In: Flick U, Kardorff E, Steinke I, editors. A companion to qualitative research. London: Sage Publications; 2004. p. 266–9.
32.
Zurück zum Zitat Mokkink LB, Terwee CB, Knol DL, et al. The COSMIN checklist for evaluating the methodological quality of studies on measurement properties: a clarification of its content. BMC Med Res Methodol. 2010;10:22.CrossRefPubMedPubMedCentral Mokkink LB, Terwee CB, Knol DL, et al. The COSMIN checklist for evaluating the methodological quality of studies on measurement properties: a clarification of its content. BMC Med Res Methodol. 2010;10:22.CrossRefPubMedPubMedCentral
Metadaten
Titel
Feasibility of Using Qualitative Interviews to Explore Patients’ Treatment Goals: Experience from Dermatology
verfasst von
Christine Blome
Kathrin von Usslar
Matthias Augustin
Publikationsdatum
01.06.2016
Verlag
Springer International Publishing
Erschienen in
The Patient - Patient-Centered Outcomes Research / Ausgabe 3/2016
Print ISSN: 1178-1653
Elektronische ISSN: 1178-1661
DOI
https://doi.org/10.1007/s40271-015-0149-5

Weitere Artikel der Ausgabe 3/2016

The Patient - Patient-Centered Outcomes Research 3/2016 Zur Ausgabe